Structural heart refers to a subspecialty within cardiology that focuses on the diagnosis and treatment of structural abnormalities or diseases of the heart, particularly those affecting the valves, chambers, and surrounding structures. It typically involves minimally invasive procedures performed in a catheterization laboratory rather than open-heart surgery.
Sizing and Forecast
The structural heart market size has grown strongly in recent years. It will grow from $14.13 billion in 2023 to $15.3 billion in 2024 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increased awareness and screening, supply chain resilience, increasing healthcare expenditure, market concentration, increasing awareness of cardiovascular diseases..
The structural heart market size is expected to see strong growth in the next few years. It will grow to $20.69 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to demand for heart valve devices, aging population, growing burden of cardiovascular diseases, market segmentation, regional market growth.. Major trends in the forecast period include product launches, technological advancements, economic recovery, regulatory impositions, rising incidences of cardiovascular diseases, innovative medical devices..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report
Segmentation & Regional Insights
The structural heart market covered in this report is segmented –
1) By Product: Occluders, Annuloplasty Rings, Heart Valve Balloons, Other Products
2) By Procedure: Heart Valve Stenosis, Heart Valve Regurgitation, Left Atrial Appendage Closure
3) By End Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers
North America was the largest region in the structural heart market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12029&type=smp
Major Driver Impacting Market Growth
The rising prevalence of cardiovascular disorders is expected to propel the growth of the structural heart market going forward. Cardiovascular disorders are diseases that affect the heart and blood vessels and include conditions such as coronary artery disease, heart failure, and stroke. The rising prevalence of cardiovascular disorders is mostly driven by the aging population, changes in lifestyle and diet, and increasing rates of obesity and diabetes. Structural heart devices and services offer diagnosis and treatment of structural heart anomalies or disorders that affect the valves, chambers, and surrounding tissues using minimally invasive procedures performed rather than open-heart surgery for efficient treatment with lower-risk complications. For instance, in August 2022, according to a report published by the American College of Cardiology, a US-based non-profit medical association, In the United States, it is anticipated that all four cardiovascular risk factors will increase between 2025 and 2060. The largest percentage rise is expected in diabetes, with a 39.3% increase to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). The researchers also observed that the most substantial projected increases in cardiovascular disease rates were for stroke (33.8% to 15 million) and heart failure (33.4% to 13 million), followed by ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million). Therefore, the rising prevalence of cardiovascular disorders is driving the growth of the structural heart market.
Key Industry Players
Major companies operating in the structural heart market report are Abbott Laboratories, Comed BV, Medtronic plc, Labcor Laboratórios Ltda., Boston Scientific Corporation, Edwards Lifesciences Corporation, Trane Technologies, Lepu Medical Technology Co. Ltd., LivaNova PLC, Biomerics LLC, Venus Medtech (Hangzhou) Inc., Cryolife Inc., Endologix Inc., Shockwave Medica Inc., Braile Biomédica, JenaValve Technology Inc., Corvia Medical Inc, HLT Medical, On-X Life Technologies Inc., Symetis SA, Magenta Therapeutics, PASCAL Medical, Micro Interventional Devices Inc., CardioKinetix Inc, XELTIS BV, Tendyne Holdings Inc., Q’Apel Medical Inc., Neovasc Inc., NVT AG, XpandOrtho Inc., Z-Medical GmbH + Co. KG
The structural heart market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
